Vomeronasal 1 receptor 115 activators are compounds that can influence the receptor's activity through various signaling pathways, particularly involving cyclic nucleotides like cAMP and cGMP. Forskolin is a potent activator of adenylyl cyclase, leading to an increase in intracellular cAMP, enhancing the signaling pathways of vomeronasal 1 receptor 115. Similarly, IBMX and Luteolin work as phosphodiesterase inhibitors, preventing the breakdown of cAMP, and thereby sustaining and enhancing the cAMP-dependent signaling which is crucial for the activation of vomeronasal 1 receptor 115. Resveratrol, through its activation of sirtuins, can indirectly influence adenylyl cyclase activity, leading to increased cAMP and subsequent activation of vomeronasal 1 receptor 115.
Other compounds such as Zaprinast and Sildenafil selectively inhibit phosphodiesterase 5, which increases cGMP levels. Elevated cGMP can indirectly influence cAMP pathways, which are involved in vomeronasal 1 receptor 115 signaling, potentially enhancing its activity. Rolipram and Vinpocetine, by inhibiting other subtypes of phosphodiesterases, lead to an increase in cAMP and cGMP levels, thereby facilitating the activation of vomeronasal 1 receptor 115. Curcumin, with its effects on various signal transduction pathways, including the cAMP pathway, and Ginsenoside Rg3, by modulating adenylyl cyclase activity, have the potential to enhance the activity of vomeronasal 1 receptor 115. Theophylline and Isobutylmethylxanthine further contribute to the increase in cAMP levels, enhancing the cAMP-dependent signaling pathways that vomeronasal1 receptor 115 utilizes for its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, leading to an accumulation of cAMP, which indirectly upregulates vomeronasal 1 receptor 115 activity by sustaining the cAMP signaling cascade. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin, a flavonoid known to inhibit phosphodiesterases, increases cAMP levels, thereby potentially enhancing vomeronasal 1 receptor 115 signaling through cAMP-mediated pathways. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol stimulates sirtuins which can affect adenylyl cyclase activity, thereby potentially increasing cAMP and enhancing vomeronasal 1 receptor 115 signaling. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5, raising cGMP levels, which might enhance cAMP pathways indirectly and activate vomeronasal 1 receptor 115. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to elevated cAMP levels and thus may indirectly enhance vomeronasal 1 receptor 115 activity by strengthening cAMP signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin modulates various signal transduction pathways including the cAMP pathway, possibly leading to the enhancement of vomeronasal 1 receptor 115 activity. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine inhibits phosphodiesterase 1, which can lead to raised cAMP and cGMP levels, possibly promoting vomeronasal 1 receptor 115 activity through these signaling pathways. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, by inhibiting phosphodiesterases, increases cAMP concentration, which may enhance vomeronasal 1 receptor 115 signaling via cAMP-dependent pathways. | ||||||